Skip to content
Skip to the content
KSAS Shield

Gallagher Lab Department of Psychological and Brain Sciences

  • Home
  • People
  • Cognition & Hippocampal
  • Neurogenetics and Behavior Center
    • Cognitive Module
    • Affective Module
    • Sensorimotor Module
  • Join the Lab
  • Events
  • Publications
  • News Archive
  • Data
    • Young Learning Activated Microarray Dataset
    • Basal Aging Microarray Dataset
  • Former Trainees
  • Links
  • PBS Home
Gallagher Lab > News Archive > A NEW DRUG BEING DEVELOPED BY TWO JHU RESEARCHERS OFFERS HOPE FOR ALZHEIMER’S PATIENTS

A NEW DRUG BEING DEVELOPED BY TWO JHU RESEARCHERS OFFERS HOPE FOR ALZHEIMER’S PATIENTS

September 27, 2021September 27, 2021

Michela Gallagher and Marilyn Albert are in the late stages of testing a drug that appears to slow the progression of Alzheimer’s disease.

  • Home
  • People
  • Cognition & Hippocampal
  • Neurogenetics and Behavior Center
    • Cognitive Module
    • Affective Module
    • Sensorimotor Module
  • Join the Lab
  • Events
  • Publications
  • News Archive
  • Data
    • Young Learning Activated Microarray Dataset
    • Basal Aging Microarray Dataset
  • Former Trainees
  • Links
  • PBS Home

JHU shield in the footer
  • Accessibility
  • Privacy Statement
Facebook Instagram Twitter YouTube TikTok

© 2023 Johns Hopkins University,
Zanvyl Krieger School of Arts & Sciences,
3400 N. Charles St, Baltimore, MD 21218